• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?

作者信息

Gold Michael R

机构信息

Medical University of South Carolina, Charleston.

出版信息

Circulation. 2018 Jan 16;137(3):217-218. doi: 10.1161/CIRCULATIONAHA.117.030096.

DOI:10.1161/CIRCULATIONAHA.117.030096
PMID:29335282
Abstract
摘要

相似文献

1
Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?亚临床房颤的治疗：1加1是否永远等于2？
Circulation. 2018 Jan 16;137(3):217-218. doi: 10.1161/CIRCULATIONAHA.117.030096.
2
Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation.房颤负荷与房颤类型：临床意义及对卒中风险和长期抗凝决策的影响
Vascul Pharmacol. 2016 Aug;83:26-35. doi: 10.1016/j.vph.2016.03.006. Epub 2016 May 16.
3
Atrial fibrillation and stroke: are we looking in the right direction?心房颤动与中风：我们找对方向了吗？
Cardiovasc Res. 2022 Jan 7;118(1):e4-e5. doi: 10.1093/cvr/cvab341.
4
Recommendations on stroke prevention for patients having a CHADS-VASc score of 1 (males) or 2 (females) in 2019 atrial fibrillation guidelines.2019年心房颤动指南中针对CHADS-VASc评分为1（男性）或2（女性）的患者的卒中预防建议。
Trends Cardiovasc Med. 2019 Oct;29(7):427-428. doi: 10.1016/j.tcm.2019.02.008. Epub 2019 Feb 25.
5
Stroke risk in female patients with atrial fibrillation: Relationship to current guideline recommendations.女性房颤患者的卒中风险：与现行指南建议的关系。
Trends Cardiovasc Med. 2019 Apr;29(3):150-152. doi: 10.1016/j.tcm.2018.07.003. Epub 2018 Jul 12.
6
Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.评估口服抗凝药减少中国经器械检测发现的无症状性心房颤动患者血栓栓塞事件（ART-CAF）试验的原理和设计：一项基于开放性登记的临床试验。
Cardiovasc Drugs Ther. 2018 Aug;32(4):389-396. doi: 10.1007/s10557-018-6807-9.
7
Unsolved issues in oral anticoagulation treatment in atrial fibrillation.心房颤动口服抗凝治疗中的未解决问题。
Eur Heart J Cardiovasc Pharmacother. 2019 Apr 1;5(2):60-61. doi: 10.1093/ehjcvp/pvz008.
8
When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topics.心房颤动时何时停用口服抗凝药——常见临床讨论话题概述
Vasc Health Risk Manag. 2019 Sep 17;15:399-408. doi: 10.2147/VHRM.S187656. eCollection 2019.
9
Implementation of a Fast Healthcare Interoperability Resources-Based Clinical Decision Support Tool for Calculating CHADS-VASc Scores.基于快速医疗保健互操作性资源的CHADS-VASc评分计算临床决策支持工具的实施
Circ Cardiovasc Qual Outcomes. 2020 Feb;13(2):e006286. doi: 10.1161/CIRCOUTCOMES.119.006286. Epub 2020 Feb 6.
10
Underuse of Oral Anticoagulants for Nonvalvular Atrial Fibrillation: Past, Present, and Future.非瓣膜性心房颤动口服抗凝剂的使用不足：过去、现在与未来
Tex Heart Inst J. 2016 Aug 1;43(4):287-90. doi: 10.14503/THIJ-16-5785. eCollection 2016 Aug.

引用本文的文献

1
Challenges and Opportunities for Atrial Fibrillation Management.心房颤动管理的挑战与机遇
Cardiol Discov. 2025 Jun;5(2):149-161. doi: 10.1097/CD9.0000000000000155. Epub 2025 Apr 10.
2
New electrocardiographic score for the prediction of atrial fibrillation: The MVP ECG risk score (morphology-voltage-P-wave duration).用于预测心房颤动的新心电图评分：MVP心电图风险评分（形态-电压-P波时限）。
Ann Noninvasive Electrocardiol. 2019 Nov;24(6):e12669. doi: 10.1111/anec.12669. Epub 2019 Jun 11.
3
Identification of paroxysmal atrial fibrillation subtypes in over 13,000 individuals.
在超过 13000 个人中识别阵发性心房颤动亚型。
Heart Rhythm. 2019 Jan;16(1):26-30. doi: 10.1016/j.hrthm.2018.08.012. Epub 2018 Aug 14.